BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30824181)

  • 21. Peri-operative hyperglycemia is associated with delayed graft function in deceased donor renal transplantation.
    Parekh J; Roll GR; Feng S; Niemann CU; Hirose R
    Clin Transplant; 2013; 27(4):E424-30. PubMed ID: 23808826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Batal I; Mohan S; De Serres SA; Vasilescu ER; Tsapepas D; Crew RJ; Patel SS; Serban G; McCune K; Husain SA; Chang JH; Herter JM; Bhagat G; Markowitz GS; D'Agati VD; Hardy MA; Ratner L; Chandraker A
    Kidney Int; 2018 May; 93(5):1227-1239. PubMed ID: 29544662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired ATG16L-Dependent Autophagy Promotes Renal Interstitial Fibrosis in Chronic Renal Graft Dysfunction Through Inducing EndMT by NF-κB Signal Pathway.
    Gui Z; Suo C; Wang Z; Zheng M; Fei S; Chen H; Sun L; Han Z; Tao J; Ju X; Yang H; Gu M; Tan R
    Front Immunol; 2021; 12():650424. PubMed ID: 33927720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients.
    See EJ; Hawley CM; Cho Y; Toussaint ND; Agar JW; Pascoe EM; Lim WH; Francis RS; Collins MG; Johnson DW
    Nephrology (Carlton); 2019 Jan; 24(1):111-120. PubMed ID: 29316017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective postreperfusion metabolic recovery directly associates with incident delayed graft function.
    Wijermars LG; Schaapherder AF; de Vries DK; Verschuren L; Wüst RC; Kostidis S; Mayboroda OA; Prins F; Ringers J; Bierau J; Bakker JA; Kooistra T; Lindeman JH
    Kidney Int; 2016 Jul; 90(1):181-91. PubMed ID: 27188504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischemia Reperfusion Injury Triggers CXCL13 Release and B-Cell Recruitment After Allogenic Kidney Transplantation.
    Kreimann K; Jang MS; Rong S; Greite R; von Vietinghoff S; Schmitt R; Bräsen JH; Schiffer L; Gerstenberg J; Vijayan V; Dittrich-Breiholz O; Wang L; Karsten CM; Gwinner W; Haller H; Immenschuh S; Gueler F
    Front Immunol; 2020; 11():1204. PubMed ID: 32849490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor simvastatin treatment prevents ischemia-reperfusion and acute kidney injury by preserving microvascular barrier function.
    Tuuminen R; Nykänen AI; Saharinen P; Gautam P; Keränen MA; Arnaudova R; Rouvinen E; Helin H; Tammi R; Rilla K; Krebs R; Lemström KB
    Am J Transplant; 2013 Aug; 13(8):2019-34. PubMed ID: 23773358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysis.
    Zens TJ; Danobeitia JS; Leverson G; Chlebeck PJ; Zitur LJ; Redfield RR; D'Alessandro AM; Odorico S; Kaufman DB; Fernandez LA
    Clin Transplant; 2018 Mar; 32(3):e13190. PubMed ID: 29314286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Pre-Transplant Caveolin-1 Serum Concentrations Are Associated with Acute Cellular Tubulointerstitial Rejection in Kidney Transplantation.
    Emmerich F; Zschiedrich S; Reichenbach-Braun C; Süsal C; Minguet S; Pauly MC; Seidl M
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulated necrosis in kidney ischemia-reperfusion injury.
    Pefanis A; Ierino FL; Murphy JM; Cowan PJ
    Kidney Int; 2019 Aug; 96(2):291-301. PubMed ID: 31005270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Remote Ischemic Conditioning of Benefit to Patients Undergoing Kidney Transplantation?
    Cheungpasitporn W; Khoury NJ; Thongprayoon C; Craici IM
    J Invest Surg; 2019 Jan; 32(1):72-74. PubMed ID: 29023177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
    Ponticelli C
    Nephrol Dial Transplant; 2014 Jun; 29(6):1134-40. PubMed ID: 24335382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Gill J; Dong J; Rose C; Gill JS
    Kidney Int; 2016 Jun; 89(6):1331-6. PubMed ID: 27165823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corin Is Downregulated in Renal Ischemia/Reperfusion Injury and Is Associated with Delayed Graft Function after Kidney Transplantation.
    Hu X; Su M; Lin J; Zhang L; Sun W; Zhang J; Tian Y; Qiu W
    Dis Markers; 2019; 2019():9429323. PubMed ID: 30766618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure.
    Seno A; Takeda Y; Matsui M; Okuda A; Nakano T; Nakada Y; Kumazawa T; Nakagawa H; Nishida T; Onoue K; Somekawa S; Watanabe M; Kawata H; Kawakami R; Okura H; Uemura S; Saito Y
    Hypertension; 2016 Sep; 68(3):678-87. PubMed ID: 27480835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiopoietin-2 inhibition prevents transplant ischemia-reperfusion injury and chronic rejection in rat cardiac allografts.
    Syrjälä SO; Tuuminen R; Nykänen AI; Raissadati A; Dashkevich A; Keränen MA; Arnaudova R; Krebs R; Leow CC; Saharinen P; Alitalo K; Lemström KB
    Am J Transplant; 2014 May; 14(5):1096-108. PubMed ID: 24708486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion.
    Koo DD; Welsh KI; Roake JA; Morris PJ; Fuggle SV
    Am J Pathol; 1998 Aug; 153(2):557-66. PubMed ID: 9708815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease.
    Matsui M; Takeda Y; Uemura S; Matsumoto T; Seno A; Onoue K; Tsushima H; Morimoto K; Soeda T; Okayama S; Somekawa S; Samejima K; Kawata H; Kawakami R; Nakatani K; Iwano M; Saito Y
    Kidney Int; 2014 Feb; 85(2):393-403. PubMed ID: 24048373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours.
    Hansson J; Mjörnstedt L; Lindnér P
    Clin Transplant; 2018 Sep; 32(9):e13377. PubMed ID: 30098052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.